Where I see patients (1)
My reviews
Selected research
-
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Nature medicine
-
CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases.
Neuro-oncology advances
-
Identification of risk factors associated with leptomeningeal disease after resection of brain metastases.
Journal of neurosurgery
Contact me
- Request appointment
- Refer a patient
- (415) 353-2966
4.9